Search research articles
Contact Us
Filters
Showing results (241-250 of 252) with videos related to
Page
of 26
Sort By:
Orvosi Hetilap
|
August 26, 2011
[Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary]
Lajos Sándor Kiss, Tamás Szamosi, Tamás Molnár, et al.
BMC Neurology
|
September 19, 2021
The role of hybrid FDG-PET/MRI on decision-making in presurgical evaluation of drug-resistant epilepsy
Márton Tóth, Péter Barsi, Zoltán Tóth, et al.
Journal of Crohn'S & Colitis
|
December 15, 2015
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort
Krisztina B Gecse, Barbara D Lovász, Klaudia Farkas, et al.
Journal of Medical Systems
|
August 21, 2022
Multicenter Study on COVID-19 Lung Computed Tomography Segmentation with varying Glass Ground Opacities using Unseen Deep Learning Artificial Intelligence Paradigms: COVLIAS 1.0 Validation
Jasjit S Suri, Sushant Agarwal, Luca Saba, et al.
F1000Research
|
June 11, 2025
Healing through faith: Meeting a chaplain coupled with biblical readings could produce lymphocyte changes that correlate with brain activity (HEALING study)
András Béres, Miklós Emri, Csaba Aranyi, et al.
Inflammatory Bowel Diseases
|
September 19, 2017
Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort
Lorant Gonczi, Krisztina B Gecse, Zsuzsanna Vegh, et al.
BMC Gastroenterology
|
September 11, 2009
Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study
Pál Miheller, Péter L Lakatos, Gábor Horváth, et al.
Expert Opinion on Drug Safety
|
May 16, 2017
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort
Anita Bálint, Mariann Rutka, Zsuzsanna Végh, et al.
Plant, Cell & Environment
|
June 17, 2024
A synchronized, large-scale field experiment using Arabidopsis thaliana reveals the significance of the UV-B photoreceptor UVR8 under natural conditions
Susanne Neugart, Viktoria Steininger, Catarina Fernandes, et al.
Diagnostics (Basel, Switzerland)
|
May 28, 2022
COVLIAS 1.0<sub>Lesion</sub> vs. MedSeg: An Artificial Intelligence Framework for Automated Lesion Segmentation in COVID-19 Lung Computed Tomography Scans
Jasjit S Suri, Sushant Agarwal, Gian Luca Chabert, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 252) with videos related to
Sort By:
Page
of 26
Orvosi Hetilap
|
August 26, 2011
[Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary]
Lajos Sándor Kiss, Tamás Szamosi, Tamás Molnár, et al.
BMC Neurology
|
September 19, 2021
The role of hybrid FDG-PET/MRI on decision-making in presurgical evaluation of drug-resistant epilepsy
Márton Tóth, Péter Barsi, Zoltán Tóth, et al.
Journal of Crohn'S & Colitis
|
December 15, 2015
Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort
Krisztina B Gecse, Barbara D Lovász, Klaudia Farkas, et al.
Journal of Medical Systems
|
August 21, 2022
Multicenter Study on COVID-19 Lung Computed Tomography Segmentation with varying Glass Ground Opacities using Unseen Deep Learning Artificial Intelligence Paradigms: COVLIAS 1.0 Validation
Jasjit S Suri, Sushant Agarwal, Luca Saba, et al.
F1000Research
|
June 11, 2025
Healing through faith: Meeting a chaplain coupled with biblical readings could produce lymphocyte changes that correlate with brain activity (HEALING study)
András Béres, Miklós Emri, Csaba Aranyi, et al.
Inflammatory Bowel Diseases
|
September 19, 2017
Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort
Lorant Gonczi, Krisztina B Gecse, Zsuzsanna Vegh, et al.
BMC Gastroenterology
|
September 11, 2009
Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study
Pál Miheller, Péter L Lakatos, Gábor Horváth, et al.
Expert Opinion on Drug Safety
|
May 16, 2017
Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort
Anita Bálint, Mariann Rutka, Zsuzsanna Végh, et al.
Plant, Cell & Environment
|
June 17, 2024
A synchronized, large-scale field experiment using Arabidopsis thaliana reveals the significance of the UV-B photoreceptor UVR8 under natural conditions
Susanne Neugart, Viktoria Steininger, Catarina Fernandes, et al.
Diagnostics (Basel, Switzerland)
|
May 28, 2022
COVLIAS 1.0<sub>Lesion</sub> vs. MedSeg: An Artificial Intelligence Framework for Automated Lesion Segmentation in COVID-19 Lung Computed Tomography Scans
Jasjit S Suri, Sushant Agarwal, Gian Luca Chabert, et al.
Page
of 26